Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 14,125 | 15,501 | 16,324 | 17,000 | 18,700 |
| Operating Income | -14,125 | -15,501 | -16,324 | -17,000 | -18,700 |
| Other Income | 622 | 802 | 934 | 1,075 | 1,258 |
| Pre-tax Income | -13,503 | -14,699 | -15,390 | -15,925 | -17,442 |
| Net Income Continuous | -13,503 | -14,699 | -15,390 | -15,925 | -17,442 |
| Net Income | $-13,503 | $-14,699 | $-15,390 | $-15,925 | $-17,442 |
| EPS Basic Total Ops | -0.98 | -1.09 | -1.14 | -1.19 | 96.46 |
| EPS Basic Continuous Ops | -0.99 | -1.09 | -1.14 | -1.19 | 96.46 |
| EPS Diluted Total Ops | -0.98 | -1.09 | -1.14 | -1.19 | 96.46 |
| EPS Diluted Continuous Ops | -0.99 | -1.09 | -1.14 | -1.19 | 96.46 |
| EPS Diluted Before Non-Recurring Items | -0.99 | -1.09 | -1.14 | -1.19 | -1.37 |
| EBITDA(a) | $-13,923 | $-15,297 | $-16,112 | $-16,788 | $-18,478 |